Key result
TTNtv-associated cardiomyopathy linked to ~47 mL/m² greater LVESVI reduction during LVAD support than ICM.
Why the study?
The remodeling potential of titin truncating variant-associated cardiomyopathy during durable mechanical unloading with LVAD support is unknown.
Does TTNtv-associated cardiomyopathy predict greater structural reverse remodeling during LVAD support compared to other cardiomyopathies in adults?
Cohort (n=51)
No
Does TTNtv-associated cardiomyopathy predict greater structural reverse remodeling during LVAD support compared to other cardiomyopathies in adults?
Mean Difference: -47.2 (95% CI -75.9–-18.4)
Absolute Event Rate: 87.7% vs 32.6%
p-value: p=0.002
Patients with TTN truncating variant-associated cardiomyopathy experience significantly greater structural reverse remodeling during LVAD support compared to those with other nonischemic or ischemic cardiomyopathies.
TTNtv cardiomyopathy may show enhanced LVAD reverse remodeling; extends GDMT observations but leaves open genotype-guided candidacy or weaning.
Background Myocardial recovery sufficient for left ventricular assist device (LVAD) explantation remains uncommon. Titin truncating variant (TTNtv)-associated cardiomyopathy demonstrates favorable reverse remodeling with medical therapy, but its remodeling potential during durable mechanical unloading is unknown. Methods We conducted a retrospective, single-center study of adults undergoing HeartMate 3 LVAD implantation from 2016–2025. Patients were categorized as TTNtv-associated cardiomyopathy, other genetically characterized nonischemic cardiomyopathy (NICM), or ischemic cardiomyopathy (ICM). The primary endpoint was absolute change in left ventricular end-systolic volume index (LVESVI) during LVAD support. Multivariable and sensitivity analyses evaluated potential confounding and influential observations. Results Among 51 patients, 7 had TTNtv-associated cardiomyopathy, 9 other NICM, and 35 ICM. TTNtv patients were younger than other NICM and ICM patients (40.5±15.8 vs 45.8±11.0 vs 67.4±9.3 years; P <0.001). Mean LVESVI decreased by 87.7±71.8 mL/m² in TTNtv patients compared with 30.4±28.3 mL/m² in other NICM and 32.6±30.6 mL/m² in ICM ( P =0.039). Compared with ICM, TTNtv status remained associated with greater LVESVI reduction after adjustment for baseline LV end-diastolic diameter (β=−47.2 mL/m²; 95% CI, −75.9 to −18.4; P =0.002). Findings were directionally consistent across sensitivity analyses addressing age, post-LVAD guideline-directed medical therapy, follow-up duration, cardiomyopathy substrate, and influential observations. TTNtv patients more frequently met volumetric reverse remodeling criteria (85.7% vs 22.2% vs 57.1%; P =0.044). Conclusions TTNtv-associated cardiomyopathy was associated with greater structural reverse remodeling during LVAD support, particularly LVESVI reduction. Although limited by the small TTNtv cohort and potential residual confounding, these hypothesis-generating findings suggest that genetic substrate may contribute to myocardial remodeling during mechanical unloading.
No takes yet. Share an insight, caveat, or question.
Cole et al. (2026) conducted a cohort in Heart failure requiring LVAD (n=51). TTNtv-associated cardiomyopathy vs. Ischemic cardiomyopathy (ICM) or other nonischemic cardiomyopathy (NICM) was evaluated on Absolute change in left ventricular end-systolic volume index (LVESVI) during LVAD support (β=-47.2 mL/m², 95% CI -75.9 to -18.4, p=0.002). TTNtv-associated cardiomyopathy was associated with greater left ventricular end-systolic volume index reduction during LVAD support compared with ischemic cardiomyopathy (β=-47.2 mL/m²; P=0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: